Phase 1b results of avelumab in patients (pts) with previously treated metastatic melanoma enrolled in the JAVELIN Solid Tumor trial, including updated subgroup analyses.

Keilholz, U; Mehnert, JM; Bauer, S; Bourgeois, HP; Patel, MR; Gravenor, D; Nemunaitis, JJ; Taylor, MH; Wyrwicz, L; Lee, KW; Kasturi, V; Chin, KM; von Heydebreck, A; Gulley, JL

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):